10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad

July 27, 2021 at 6:30 AM EDTPDF Version Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes  PLEASANTON, Calif., July 27, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The... Read more

PerkinElmer’s COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type

Non-invasive sampling method makes it easier to use the highly sensitive molecular test manufactured by PerkinElmer WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the U.S. Food and Drug Administration (FDA) has authorized the PerkinElmer® New Coronavirus Nucleic Acid Detection Kit for an additional indication that permits... Read more

Bruker Announces Date and Time of Second Quarter 2021 Earnings Release and Webcast

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2021 financial results on Monday, August 2, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can... Read more

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Third Quarter Earnings Conference Call and Webcast CHELMSFORD, Mass., July 20, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 third quarter which ended on June 30, 2021 on Thursday, August 5, 2021 after the market closes. The Company will host a conference call and live webcast to... Read more

Thermo Fisher Scientific Expands Hematology Oncology NGS Portfolio

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers CARLSBAD, Calif., July 19, 2021 /PRNewswire/ — Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune... Read more

Xylem Announces Earnings Call Time Change: Second Quarter 2021 Earnings Call To Occur On August 3, 2021 At 11 a.m. EDT

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 15, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced an update to the timing of its previously announced second quarter earnings conference call. The Company will release its second quarter 2021 results at 6:55 a.m. (EDT) on... Read more

10x Genomics Introduces New Chromium X Series for Single Cell Analysis

July 14, 2021 at 8:01 AM EDTPDF Version Million-Cell Experiments Routinely Accessible for the First Time PLEASANTON, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Building on its industry leading position in single cell analysis, 10x Genomics (NASDAQ: TXG) today announced commercial availability of its new Chromium X Series, a next-generation platform for single cell analysis.... Read more

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021 WALTHAM, Mass., July 7, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold... Read more

PerkinElmer Provides Update on Second Quarter Performance and Schedules Earnings Call for Wednesday, July 28, 2021

Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 24, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day that it anticipates exceeding its previously announced financial guidance for the second quarter... Read more